Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Mario Taylor

Orthopaedic Surgery Gilbert, AZ Medical Doctor

NPI 1407380512 CMS profile 11345004

1675 E Melrose St Ste 101-103, Gilbert, AZ 85297

Open in the dashboard

General payments

$92,557

156 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mario Taylor of Gilbert, AZ is reported in the CMS Open Payments database as having received $92,557 across 156 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,572 56
2024 General $9,764 43
2023 General $2,695 37
2022 General $59,527 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mario Taylor
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Mario Taylor were reported at $20,572. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Mario Taylor Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $59,527 $598 $128–$2,731 $149
2023 $2,695 $461 $128–$2,264 $160
2024 $9,764 $497 $134–$2,475 $164
2025 $20,572 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. NuVasive, Inc. $59,418 17 payments
  2. Globus Medical, Inc. $22,594 67 payments
  3. Kuros Biosciences USA, Inc $6,125 13 payments
  4. Medtronic, Inc. $794 10 payments
  5. DePuy Synthes Sales Inc. $781 11 payments
  6. Nevro Corp. $717 10 payments
  7. Orthofix Medical, Inc. $686 9 payments
  8. SI-BONE, Inc. $424 7 payments
  9. Abbott Laboratories $415 5 payments
  10. Stryker Corporation $153 1 payment
  11. Other $450 6 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Grant $57,780 1 payment
  2. Consulting Fee $19,700 5 payments
  3. Food and Beverage $7,614 109 payments
  4. Travel and Lodging $7,464 41 payments
Products named General payments · program years 2022–2025
  1. Anthem $15,200 4 payments
  2. MAGNETOS $6,125 13 payments
  3. TLIF $2,180 13 payments
  4. XLIF $1,792 15 payments
  5. EXCELSIUS GPS $1,749 19 payments
  6. CREO MIS Stabilization System $862 6 payments
  7. Senza $717 10 payments
  8. MARS 3V/3VL $596 2 payments
  9. Spine & Trauma 3D Navigation $408 3 payments
  10. Lattus $370 2 payments
  11. Other $5,140 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

563

Median for Orthopedic Surgery: 203

Drug cost

$3,969

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 59 $894
Gabapentin Generic 64 $768
Celecoxib Generic 51 $666
Meloxicam Generic 212 $474
Cyclobenzaprine Hcl Generic 49 $421
Oxycodone Hcl Generic 84 $411
Methylprednisolone Generic 44 $335

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$146,403

Medicare's payments for the services billed

Medicare patients

475

Average age 74

Services billed

1,365

266 women, 209 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Ischemic heart disease 31%
Diabetes 25%
Chronic kidney disease 25%
Depression 21%
Atrial fibrillation 17%
Osteoporosis 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

156 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record